A carregar...
Monoklonale Antikörper zur antiinfektiven Therapie
Sera of animal origin and hyperimmunoglobulins have dominated serum therapy for a century. Although numerous monoclonal antibodies (MABs) have been developed since the end of the 1980s, particularly for the treatment of immunological and oncological diseases, it will take 20 years before the first a...
Na minha lista:
| Publicado no: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7545799/ https://ncbi.nlm.nih.gov/pubmed/33034695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00103-020-03229-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|